Clinical Trials · NCT00542425

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Name: Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Teriparatide Abaloparatide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Radius Health, Inc.
Enrollment: 222
Start date: Apr 2007
Locations: 1 site, United States
Primary endpoint: Change in Marker of Bone Metabolism, PINP

View Teriparatide compound reference